Breast Cancer

Breast cancer survivor decides the "right" thing now, due to genetic testing results and family history, is a prophylactic double mastectomy with reconstructions

The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.

In 10-Mile Radius, a photographer shares images she captured during her cancer journey — and the insights that came with them.

One out of three men with breast cancer does not receive adequate treatment, according to recent study findings published in Annals of Oncology.

Individual advocates and larger organizations offer hope as they help us understand what future treatments are in the pipeline.

Gratitude helps get this cancer survivor through her cancer days, fears and worries.

Taking the extra time to have the more difficult conversations with your daughter about her breast health and breast cancer risk has the power to greatly improve and extend her own life.

Three years of scans every three months means finding a way to grow and change that's not limited or defined by cancer

The mission of Barbells for Boobs is to mobilize and empower people to take action against breast cancer. The organization will help people – of all ages, and regardless of insurance status or type – to get screened by connecting them with resources in their area.

After losing both my breasts and uterus, I found myself wondering what it means to be a woman.

Breast cancer survivor discusses her upcoming prophylactic double mastectomy with reconstruction.

Breast cancer survivor and flat-movement activist, Carolyn Choate, offers some rather interesting perspectives on some conventional social norms.

I am forever thankful for the care I received from my oncology care team. But I am also often frustrated by lack of knowledge for late-term effects resulting from that care.

Resilience is an important quality to possess as you're fighting breast cancer. Learn more about how it can positively affect your journey.

Brain HQ, founded by Posit Science, is a computerized brain training program, designed to improve speed of processing information and accuracy in the brain.

Until recently, Herceptin, which is used to treat patients with metastatic breast cancer, was fully covered under Humana’s South Florida Medicare Advantage plans. But, after taking it off the preferred drug list, patients will now be responsible for 20 percent of the drug’s cost, better aligning South Florida’s plans with Humana’s other Medicare Advantage plans.

As costs decrease, and physicians move to address barriers to genetic testing, a panel of physicians, researchers and a patient advocate highlighted the importance for people to get tested.

It's challenging to accept the physical limitations one may experience post-cancer, but changes to the body can pose real physical constraints.

Treatments and surgeries are a personal choice. Patients should talk with doctors and other patients and survivors to determine what is best for them.

Clinical trials designed to evaluate the use of anti-cancer drugs for the treatment of cancer typically exclude patients whose disease has spread to the brain or CNS for a number of reasons, including the misperception that they are poor clinical trial candidates.

The scars breast cancer leaves on our bodies tell a story. What will yours say?

Today women face a plethora of options. Their tumors are tested for all kinds of differences that may tell them if chemotherapy will work and which drugs would work best. There are support groups and help for families that we didn’t have.

Breast cancer survivor gives ideas to cope with genetic cancer test results worry.

The oldest cases of multiple myeloma and breast cancer date back to ancient Egyptian mummies.

When we are in situations in which others will see our cancer scars, do we have to explain them or worry about what someone else thinks?

Breast cancer survivor tries to make rational choices based on newer genetic testing results.

A recurrence is always a possibility for any victim of cancer, but should survivors expect a recurrence? If so, how can they prepare for that possibility?

As a cancer survivor, reading some information brings an uneasy feeling.

Lynparza (olaparib) was granted approval by the Food and Drug Administration (FDA) for the treatment of patients with BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy. Also, patients who have HR-positive disease should have prior endocrine therapy or they would not be considered appropriate for such treatment.

"Garden variety" breast cancer is no longer the norm thanks to the discovery of more genetic mutations.